A patent review of anticancer glucocorticoid receptor modulators (2014-present).

Expert Opinion on Therapeutic Patents
Marianna LucafòGabriele Stocco

Abstract

Introduction: Natural and synthetic glucocorticoids are widely employed in different diseases, among which are hematological and solid tumors. Their use is however associated with a number of serious side effects and by the occurrence of resistance. With the aim of separating their gene transactivating effect, more linked to side effects, from transrepressive properties, associated with therapeutic efficacy, a number of selective glucocorticoid modulators have been identified.Areas covered: This review summarizes the patent applications from 2014 to present in the field of selective glucocorticoid receptor modulators employed in cancer therapy. Only few patents have been identified, that concern the identification of new molecules or the method of use of already patented compounds. In addition, a discussion of the mechanism of action of these compounds is included.Expert opinion: Only a very limited number of patents have been applied that concern selective glucocorticoid receptor modulators and their use in cancer. Biological information is scarce for most of these patents; more research is necessary in this field in particular concerning clinical data in order to understand whether it is actually possible to improve the effic...Continue Reading

References

Jun 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·M Alexandrová, P Farkas
Apr 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·M T BocquelH Gronemeyer
Apr 19, 1996·The Journal of Biological Chemistry·R H OakleyJ A Cidlowski
Jul 11, 2000·European Journal of Cell Biology·K SchellerU Scheer
Aug 5, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·H EscrivaV Laudet
Apr 19, 2002·Steroids·Frank Buttgereit, Alexander Scheffold
Nov 21, 2002·Pharmacology & Therapeutics·Heike SchäckeKhusru Asadullah
Jan 1, 1958·Acta Pathologica Et Microbiologica Scandinavica·H G IVERSEN, G H HJORT
Jul 28, 1962·JAMA : the Journal of the American Medical Association·P SHERLOCK, W H HARTMANN
Mar 9, 2004·Molecular Biology of the Cell·Neal D Freedman, Keith R Yamamoto
Jul 3, 2004·BMJ : British Medical Journal·Munir PirmohamedAlasdair M Breckenridge
Jan 1, 2005·Current Opinion in Oncology·Olga Frankfurt, Steven T Rosen
Apr 30, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Christian PlonerReinhard Kofler
Oct 21, 2005·The New England Journal of Medicine·Turk Rhen, John A Cidlowski
Nov 30, 2005·Cellular and Molecular Life Sciences : CMLS·M J HeroldH M Reichardt
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Dec 7, 2006·Annals of the New York Academy of Sciences·Brian R Walker, Ruth Andrew
Jul 13, 2007·Molecular and Cellular Endocrinology·Alexandros Vegiopoulos, Stephan Herzig
Dec 7, 2007·Journal of Cellular and Molecular Medicine·Paraskevi Moutsatsou, Athanasios G Papavassiliou
Jan 24, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Andrew McMaster, David W Ray
Jan 30, 2008·Bioorganic & Medicinal Chemistry Letters·Robin D ClarkJoseph Belanoff
Dec 20, 2008·Molecular Endocrinology·Karolien De Bosscher, Guy Haegeman
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Jing DuHusseini K Manji
Oct 7, 2009·American Journal of Respiratory Cell and Molecular Biology·Reena BhandareOmar Tliba
Oct 16, 2010·The Lancet Oncology·Hiroto Inaba, Ching-Hon Pui
Oct 28, 2010·Current Pharmaceutical Design·Udi NussinovitchYehuda Shoenfeld
Nov 17, 2010·Cancer Letters·E Kassi, P Moutsatsou
Mar 31, 2011·World Journal of Gastroenterology : WJG·Sara De IudicibusGiuliana Decorti
Jun 15, 2011·Biochimica Et Biophysica Acta·Anna-Maria G Psarra, Constantine E Sekeris
Jul 14, 2011·Genome Research·Nagesha A S RaoHendrik G Stunnenberg
Sep 8, 2011·Arthritis and Rheumatism·Cindy StrehlFrank Buttgereit
May 24, 2012·Expert Opinion on Investigational Drugs·Lukáš Smolej
Jul 11, 2012·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Hee KangJae-Hun Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.